Screener
Innoviva, Inc. INVA Internal Expenses — Research And Development Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Innoviva, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Innoviva, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:26 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335235
| (In thousands) | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Selling and marketing | 10,335 | 8,147 | 19,837 | 16,218 |
| General and administrative | 24,236 | 18,265 | 47,172 | 37,685 |
| Research and development - External services and expenses | 2,463 | 6,782 | 5,069 | 9,833 |
| Research and development - Internal expenses | 2,727 | 1,201 | 5,362 | 2,546 |
| Changes in fair values of equity method investments, net | 131,834 | (13,082) | (25,816) | 467 |
| Changes in fair values of equity and long-term investments, net | 29,153 | (11,280) | (4,422) | 54,019 |
| Interest and dividend income | (7,599) | (4,925) | (18,586) | (9,463) |
| Interest expense | 5,472 | 4,663 | 10,909 | 9,374 |
Item 1. Financial Statements
FAQ
- What is Innoviva, Inc.'s internal expenses — research and development expense?
- Innoviva, Inc. (INVA) reported internal expenses — research and development expense of $2.73M in Q2 2026.
- How has Innoviva, Inc.'s internal expenses — research and development expense changed year-over-year?
- Innoviva, Inc.'s internal expenses — research and development expense increased by 127.1% year-over-year, from $1.2M to $2.73M.
- What is the long-term trend for Innoviva, Inc.'s internal expenses — research and development expense?
- Over 3 years (2022 to 2025), Innoviva, Inc.'s internal expenses — research and development expense has grown at a -30.9% compound annual growth rate (CAGR), from $16.77M to $5.53M.
- What does internal expenses — research and development expense mean?
- This metric represents the internal costs incurred by the company to support research and development activities within its specific operating segments. It captures the investment directed toward the discovery, clinical development, and regulatory advancement of the company's healthcare and pharmaceutical assets. Monitoring this expense helps investors evaluate the company's commitment to innovation and the sustainability of its product pipeline.
Ask your AI about Innoviva, Inc.'s internal expenses — research and development expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude